Mitsubishi UFJ Asset Management Increases Stake in ResMed

The institutional investor added nearly 10,000 shares of the medical equipment provider in the third quarter.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in ResMed Inc. (NYSE:RMD) by 3.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor now owns 289,606 shares of the medical equipment provider's stock, valued at approximately $79.3 million.

Why it matters

ResMed is a leading manufacturer of sleep apnea and respiratory care devices, and institutional investor activity in the stock can signal broader market sentiment around the company and its products. Mitsubishi UFJ Asset Management's increased stake suggests confidence in ResMed's long-term growth prospects.

The details

Mitsubishi UFJ Asset Management added 9,730 shares of ResMed in the third quarter, bringing its total position to 289,606 shares. The firm now owns about 0.20% of ResMed's outstanding shares. Other notable institutional investors in ResMed include Jones Financial Companies Lllp, Howard Capital Management Inc., and Spire Wealth Management.

  • Mitsubishi UFJ Asset Management increased its ResMed holdings in the third quarter of 2026.

The players

Mitsubishi UFJ Asset Management Co. Ltd.

An institutional investor that manages assets on behalf of clients.

ResMed Inc.

A medical equipment provider that specializes in sleep apnea and respiratory care devices.

Got photos? Submit your photos here. ›

The takeaway

Mitsubishi UFJ Asset Management's increased stake in ResMed suggests the institutional investor sees long-term growth potential in the medical device company, which could signal broader market confidence in ResMed's products and market position.